CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Positive
AI Analysis

Summary

Immunology specialist Khartis Therapeutics, founded by the former XinThera team acquired by Gilead, emerged from stealth mode with $95 million in funding.

Importance:5/10
Sentiment:
0.60
fundingimmunologystealth launchGilead spinout
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 14, 2026 10:08 AM

Read Original